HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Jer-Tsong Hsieh Selected Research

adenovirus receptor

6/2011Coxsackie and adenovirus receptor is a target and a mediator of estrogen action in breast cancer.
3/2007A histone deacetylase inhibitor enhances adenoviral infection of renal cancer cells.
12/2006Valproic acid, a histone deacetylase inhibitor, is an antagonist for oncolytic adenoviral gene therapy.
9/2006Mechanism of increased coxsackie and adenovirus receptor gene expression and adenovirus uptake by phytoestrogen and histone deacetylase inhibitor in human bladder cancer cells and the potential clinical application.
8/2005Enhanced transgene expression in urothelial cancer gene therapy with histone deacetylase inhibitor.
12/2003Epigenetic regulation of coxsackie and adenovirus receptor (CAR) gene promoter in urogenital cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Jer-Tsong Hsieh Research Topics

Disease

52Neoplasms (Cancer)
12/2015 - 01/2002
49Prostatic Neoplasms (Prostate Cancer)
12/2015 - 01/2002
12Urinary Bladder Neoplasms (Bladder Cancer)
12/2015 - 12/2003
8Neoplasm Metastasis (Metastasis)
07/2014 - 03/2007
5Transitional Cell Carcinoma
07/2011 - 07/2005
3Breast Neoplasms (Breast Cancer)
01/2012 - 03/2004
3Carcinoma (Carcinomatosis)
02/2010 - 03/2007
3Urogenital Neoplasms
01/2004 - 07/2003
2Ataxia Telangiectasia (Louis Bar Syndrome)
04/2015 - 07/2014
2Fibrosis (Cirrhosis)
05/2010 - 07/2006
2Infection
03/2007 - 08/2005
1Disease Progression
06/2015
1Communicable Diseases (Infectious Diseases)
06/2015
1Urinary Tract Infections (Urinary Tract Infection)
01/2015
1Inflammation
01/2015
1Anoxia (Hypoxia)
11/2014
1Stomach Neoplasms (Stomach Cancer)
05/2014

Drug/Important Bio-Agent (IBA)

10DNA (Deoxyribonucleic Acid)IBA
04/2015 - 05/2002
10Histone Deacetylase InhibitorsIBA
02/2008 - 12/2003
7romidepsin (FK228)FDA Link
11/2008 - 12/2003
7Messenger RNA (mRNA)IBA
06/2006 - 04/2002
6adenovirus receptorIBA
06/2011 - 12/2003
5Histones (Histone)IBA
09/2015 - 12/2003
5Proteins (Proteins, Gene)IBA
04/2015 - 04/2002
5Androgen Receptors (Androgen Receptor)IBA
10/2013 - 11/2005
3Biological Markers (Surrogate Marker)IBA
12/2015 - 07/2003
3PolymersIBA
09/2015 - 05/2013
3lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
04/2015 - 12/2012
3Transcription Factors (Transcription Factor)IBA
03/2014 - 05/2012
3docetaxel (Taxotere)FDA Link
09/2013 - 01/2002
3RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
03/2007 - 06/2006
2MicroRNAs (MicroRNA)IBA
12/2015 - 09/2015
2Lysine (L-Lysine)FDA Link
09/2015 - 11/2011
2polyarginineIBA
09/2015 - 09/2006
2CholesterolIBA
06/2015 - 01/2015
2cytolethal distending toxinIBA
07/2014 - 05/2014
21,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
07/2014 - 04/2010
2PeptidesIBA
05/2013 - 11/2011
2Dendrimers (Dendrons)IBA
03/2013 - 07/2008
2GenisteinIBA
10/2012 - 09/2006
2Arginine (L-Arginine)FDA Link
04/2012 - 11/2011
23- (2- carboxypiperazin- 4- yl)propyl- 1- phosphonic acid (CPP)IBA
04/2012 - 09/2006
2Integrin-Binding SialoproteinIBA
11/2011 - 07/2006
2AntibodiesIBA
06/2011 - 10/2003
2Estradiol (Estrace)FDA LinkGeneric
06/2011 - 06/2006
2Phenobarbital (Luminal)FDA Link
05/2011 - 05/2011
2Carbon MonoxideIBA
05/2011 - 08/2005
2NAD (NADH)IBA
10/2010 - 02/2008
2Cadherins (E-Cadherin)IBA
02/2010 - 01/2004
2GoldIBA
02/2008 - 08/2007
2Hematoxylin (Haematoxylon)IBA
02/2008 - 07/2006
2Eosine Yellowish-(YS) (Eosin)IBA
02/2008 - 07/2006
2RNA (Ribonucleic Acid)IBA
03/2007 - 08/2005
2beta-Galactosidase (Lactaid)IBA
03/2007 - 08/2005
2Cell Adhesion MoleculesIBA
01/2004 - 04/2002
1tebufenozide (Mimic)IBA
12/2015
1P-GlycoproteinIBA
12/2015
1pirarubicinIBA
12/2015
18- dibenzothiophen- 4- yl- 2- morpholin- 4- yl- chromen- 4- oneIBA
05/2015
1Radiation-Sensitizing AgentsIBA
05/2015
1polylactic acid-polyglycolic acid copolymer (PLGA)IBA
05/2015
1bavituximabIBA
04/2015
1DNA-Activated Protein KinaseIBA
04/2015
1Anti-Bacterial Agents (Antibiotics)IBA
01/2015
1LuciferasesIBA
11/2014
1S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA
08/2014
1Prostate-Specific Antigen (Semenogelase)IBA
07/2014
12'-hydroxyflavanoneIBA
07/2014
1Metformin (Glucophage)FDA LinkGeneric
06/2014
1Heparin (Liquaemin)FDA LinkGeneric
05/2014
1ChitosanIBA
05/2014
1CopperIBA
04/2014
1Small Interfering RNA (siRNA)IBA
04/2014
1cupric chloride (copper(II) chloride)FDA Link
04/2014
1copper transporter 1IBA
04/2014
1degrasynIBA
03/2014
1UbiquitinIBA
03/2014
1Serine Proteases (Serine Protease)IBA
03/2014
1Cyclin-Dependent Kinase 5IBA
10/2013
1ClusterinIBA
09/2013
1procollagen Type I N-terminal peptide (P-I-P)IBA
08/2013
1ferric oxide (iron oxide)IBA
05/2013
1AllylamineIBA
05/2013
1poly-N-isopropylacrylamideIBA
05/2013
1PeptidomimeticsIBA
01/2013
1A-Form DNA (A-DNA)IBA
12/2012
1peptide IIBA
04/2012
1EphA2 ReceptorIBA
01/2012

Therapy/Procedure

14Heterologous Transplantation (Xenotransplantation)
04/2015 - 04/2007
5Drug Therapy (Chemotherapy)
12/2015 - 01/2002
5Castration
07/2014 - 04/2012
3Radiotherapy
12/2015 - 05/2013
3Cystectomy
11/2007 - 03/2007
2Aftercare (After-Treatment)
05/2013 - 05/2006
2Therapeutics
03/2013 - 10/2012
2Lasers (Laser)
02/2008 - 08/2007
1Adjuvant Radiotherapy
06/2014
1Intravenous Injections
04/2014
1Combined Modality Therapy
05/2013
1Individualized Medicine
03/2013